Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPfizer Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | $0.63 | $0.78 | $0.71 |
| Q2 2025 | 3 | $0.56 | $0.59 | $0.57 |
| Q3 2025 | 3 | $0.88 | $0.92 | $0.89 |
| Q4 2025 | 3 | $0.65 | $0.69 | $0.67 |
| Q1 2026 | 2 | $0.80 | $0.84 | $0.82 |
| Q2 2026 | 2 | $0.61 | $0.65 | $0.63 |
| Q3 2026 | 2 | $0.97 | $1.02 | $0.99 |
| Q4 2026 | 2 | $0.63 | $0.67 | $0.65 |
Pfizer Inc. Earnings Date And Information
Pfizer Inc. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $1.06 earnings per share for the quarter, topping analysts' consensus estimates of $0.614 by $0.446. The company had revenue of 17.70 B for the quarter and had revenue of 58.50 B for the year. Pfizer Inc. has generated $0 earnings per share over the last year ($0.37 diluted earnings per share) and currently has a price-to-earnings ratio of 35.13. Pfizer Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based on prior year's report dates.
Pfizer Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | $0.79 | $14.92 B | $17.70 B | ||
| 08/05/2024 | Q2 2024 | $0.00 | $13.28 B | |||
| 05/08/2024 | Q1 2024 | $0.55 | $14.88 B | |||
| 02/22/2024 | Q4 2023 | -$0.59 | $14.25 B | |||
| 11/08/2023 | Q3 2023 | -$0.42 | $13.23 B | |||
| 08/09/2023 | Q2 2023 | $0.41 | $12.73 B | |||
| 05/10/2023 | Q1 2023 | $0.98 | $18.28 B | |||
| 02/23/2023 | Q4 2022 | $0.89 | $24.29 B | |||
| 11/09/2022 | Q3 2022 | $1.54 | $22.64 B | |||
| 08/10/2022 | Q2 2022 | $1.77 | $27.74 B | |||
| 05/11/2022 | Q1 2022 | $1.40 | $25.66 B | |||
| 02/24/2022 | Q4 2021 | $0.60 | $23.84 B | |||
| 11/12/2021 | Q3 2021 | $1.45 | $24.09 B | |||
| 08/12/2021 | Q2 2021 | $0.99 | $18.98 B | |||
| 05/13/2021 | Q1 2021 | $0.87 | $14.58 B | |||
| 02/25/2021 | Q4 2020 | $0.11 | $11.68 B | |||
| 11/05/2020 | Q3 2020 | $0.39 | $12.13 B | |||
| 08/06/2020 | Q2 2020 | $0.63 | $11.80 B | |||
| 05/07/2020 | Q1 2020 | $0.60 | $12.03 B | |||
| 02/27/2020 | Q4 2019 | -$0.06 | $12.69 B |
Pfizer Inc. Earnings: FAQ's
When is Pfizer Inc.'s earnings date?
Pfizer Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates.
Did Pfizer Inc. beat their earnings estimates last
quarter?
In the previous quarter, Pfizer Inc. (:PFE) reported $1.06 earnings per share (EPS) to beat the analysts' consensus estimate of $0.614 by $0.446.
How can I listen to Pfizer Inc.'s earnings conference
call?
The conference call for Pfizer Inc.'s latest earnings report can be listened to online.
How can I read Pfizer Inc.'s conference call transcript?
The conference call transcript for Pfizer Inc.'s latest earnings report can be read online.
How much revenue does Pfizer Inc. generate each year?
Pfizer Inc. (:PFE) has a recorded annual revenue of $58.50 B.
How much profit does Pfizer Inc. generate each year?
Pfizer Inc. (:PFE) has a recorded net income of $58.50 B. Pfizer Inc. has generated $0.38 earnings per share over the last four quarters.
What is Pfizer Inc.'s price-to-earnings ratio?
Pfizer Inc. (:PFE) has a price-to-earnings ratio of 35.13 and price/earnings-to-growth ratio is 0.13.